Showing results (1-10 of 314) with videos related to

Sort By:
Pageof 32
The Journal of Antimicrobial Chemotherapy|July 9, 2018
Introduction to the SAVE study (2011-15): Streptococcus pneumoniae serotyping and antimicrobial susceptibility: Assessment for Vaccine Efficacy in Canada after the introduction of PCV-13George G Zhanel, Heather J Adam
Vaccine|April 17, 2016
Invasive Streptococcus pneumoniae in Canada, 2011-2014: Characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33FAlyssa R Golden, Heather J Adam, George G Zhanel, et al.
The Journal of Antimicrobial Chemotherapy|May 2, 2023
Streptococcus pneumoniae serotyping and antimicrobial susceptibility: assessment for vaccine efficacy in Canada after the introduction of PCV13George G Zhanel, Joseph P Lynch, Heather J Adam
Antimicrobial Agents and Chemotherapy|May 26, 2006
Mutant prevention concentrations of levofloxacin alone and in combination with azithromycin, ceftazidime, colistin (Polymyxin E), meropenem, piperacillin-tazobactam, and tobramycin against Pseudomonas aeruginosaGeorge G Zhanel, Matthew Mayer, Nancy Laing, et al.
International Journal of Antimicrobial Agents|August 15, 2006
Call for the international adoption of microbiological breakpoints for fluoroquinolones and Streptococcus pneumoniaeKristen N Schurek, Heather J Adam, Daryl J Hoban, et al.
International Journal of Antimicrobial Agents|April 4, 2009
Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997-2006Heather J Adam, Daryl J Hoban, Alfred S Gin, et al.
Diagnostic Microbiology and Infectious Disease|January 18, 2018
In vitro activity of eravacycline against 2213 Gram-negative and 2424 Gram-positive bacterial pathogens isolated in Canadian hospital laboratories: CANWARD surveillance study 2014-2015George G Zhanel, Melanie R Baxter, Heather J Adam, et al.
Antimicrobial Agents and Chemotherapy|October 31, 2018
In Vitro Activity of Plazomicin against Gram-Negative and Gram-Positive Bacterial Pathogens Isolated from Patients in Canadian Hospitals from 2013 to 2017 as Part of the CANWARD Surveillance StudyAndrew Walkty, James A Karlowsky, Melanie R Baxter, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 2011
In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007-2009 studyJames A Karlowsky, Heather J Adam, Susan M Poutanen, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2008
Increasing genetic relatedness of ciprofloxacin-resistant Streptococcus pneumoniae isolated in Canada from 1997 to 2005Kimberly A Nichol, Heather J Adam, James A Karlowsky, et al.
Pageof 32